AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 103 filers reported holding AVROBIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $798 | +49.4% | 518,467 | -7.8% | 0.00% | 0.0% |
| Q2 2023 | $534 | -6.8% | 562,567 | -1.9% | 0.00% | 0.0% |
| Q1 2023 | $573 | -6.8% | 573,367 | -33.5% | 0.00% | 0.0% |
| Q4 2022 | $615 | -99.9% | 862,267 | -29.4% | 0.00% | 0.0% |
| Q3 2022 | $785,000 | -45.1% | 1,222,141 | -21.4% | 0.00% | -50.0% |
| Q2 2022 | $1,431,000 | +22.5% | 1,555,800 | +75.8% | 0.00% | +100.0% |
| Q1 2022 | $1,168,000 | -5.5% | 885,100 | +175.7% | 0.00% | -50.0% |
| Q4 2021 | $1,236,000 | -45.3% | 321,000 | -20.8% | 0.00% | -33.3% |
| Q3 2021 | $2,260,000 | +185.7% | 405,100 | +355.2% | 0.00% | +200.0% |
| Q2 2021 | $791,000 | +39.8% | 89,000 | +119.2% | 0.00% | 0.0% |
| Q4 2020 | $566,000 | +184.4% | 40,600 | +165.4% | 0.00% | – |
| Q3 2020 | $199,000 | -68.8% | 15,300 | -58.1% | 0.00% | -100.0% |
| Q2 2020 | $637,000 | +145.9% | 36,530 | +129.7% | 0.00% | – |
| Q2 2019 | $259,000 | – | 15,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,191,676 | $16,612,000 | 8.00% |
| Aisling Capital Management LP | 1,009,779 | $14,076,000 | 2.42% |
| Burrage Capital Management LLC | 145,715 | $2,031,000 | 1.55% |
| Camber Capital Management LP | 3,133,333 | $43,679,000 | 1.53% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $4,399,000 | 1.02% |
| SPHERA FUNDS MANAGEMENT LTD. | 655,874 | $9,143,000 | 0.81% |
| EMERALD ADVISERS, LLC | 1,009,212 | $14,068,000 | 0.47% |
| Penn Mutual Asset Management, LLC | 37,306 | $520,000 | 0.46% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 932,627 | $13,001,000 | 0.45% |
| MPM BioImpact LLC | 364,285 | $5,078,000 | 0.44% |